Recent Updates
Recently added Catalysts
GILD Positive Sentiment

Gilead Sciences to Present at Upcoming Third Quarter 2026 Investor Conferences

Wednesday, August 26, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Gilead Sciences, Inc. has announced its participation in several upcoming investor conferences. Executives will present at the Wells Fargo Annual Healthcare Conference, Cantor Global Healthcare Conference, and Morgan Stanley Global Healthcare Conference in September 2026. Live webcasts of these presentations will be available for investors.

Market Sentiment Analysis

POSITIVE FACTORS

  • Gilead Sciences is actively engaging with investors.
  • The company is participating in multiple prestigious healthcare conferences.
  • Live webcasts provide transparency and accessibility for investors.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+15%
120-day peak, hindsight
Typical move
1.4%
average across 15 past catalysts
Lead asset
Ranolazine
Phase 2 · Diabetes Mellitus, Type 2

Full Press Release Details

FOSTER CITY, Calif.--(BUSINESS WIRE)-- #GILD--Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its executives will be speaking at the following investor conferences: Wells Fargo Annual Healthcare Conference on Wednesday, September 9 at 11:00 AM Eastern Time Cantor Global Healthcare Conference on Thursday, September 10 at 10:55 AM Eastern Time Morgan Stanley Global Healthcare Conference on Tuesday, September 15 at 10:45 AM Eastern Time The live webcasts can be accessed at the company’s investor

Frequently Asked Questions

When will Gilead Sciences present at investor conferences?

Gilead Sciences will present at investor conferences on September 9, 10, and 15, 2026.

Where can I access the live webcasts?

Live webcasts of the presentations can be accessed on Gilead's investor website.

Which conferences will Gilead participate in?

Gilead will participate in the Wells Fargo, Cantor, and Morgan Stanley conferences.

ShareAdd on Google
Tags: GILD Viatris Investor Conferences Healthcare investor conference Gilead Sciences healthcare conference webcast
Last updated: Aug 26, 2026

Biotech snapshot

Cash runway
$3179M liquidity · $0M/mo burn
Low dilution risk
Lead asset
RanolazinePhase 2
Diabetes Mellitus, Type 2 →

Catalyst track record

+15%
best trade around GILD's most recent catalyst

Peak hindsight return over a 120-day window, across 15 tracked FDA/PDUFA catalysts for GILD.

See every catalyst's timing & PoA →